Conference Description

This Mayo Clinic conference will provide reviews and updates about laboratory and clinical aspects of bleeding and thrombosing disorders. Didactic presentations will be supplemented with panel discussions and case presentations. Adequate time will be allocated for questions.

Conference Objectives

Upon completion of the conference, participants should be able to:

• Describe recommended clinical and laboratory evaluation for von Willebrand disease (VWD)
• Assess common acquired disorders of plasmatic hemostasis that lead to bleeding or thrombosis
• Recognize features of hereditary platelet disorders
• Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, or lupus anticoagulant and antiphospholipid syndrome
• Summarize clinical features and laboratory evaluation of congenital and acquired bleeding disorders
• Discuss updates in venous thromboembolism and features of newer anticoagulant drugs

Intended Audience

This program is designed for clinicians, pathologists, scientists, and laboratory technologists whose practices include bleeding and thrombosing diseases

To Register:

Click here to register